Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
15.85
-1.07 (-6.32%)
Feb 27, 2026, 12:18 PM EST - Market open
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.05 billion as of February 27, 2026. Its market cap has decreased by -3.76% in one year.
Market Cap
2.05B
Enterprise Value
2.06B
1-Year Change
-3.76%
Ranking
Category
Stock Price
$15.85
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.05B, an increase of 246.05%. That is a compound annual growth rate of 12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 2.16B | -6.27% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.43B |
| Dianthus Therapeutics | 2.30B |
| Mineralys Therapeutics | 2.28B |
| Galapagos NV | 2.26B |
| Zai Lab | 2.24B |
| Ascentage Pharma Group International | 2.24B |
| Maze Therapeutics | 2.20B |
| Ultragenyx Pharmaceutical | 2.20B |